Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Galapagos
Biotech
Rebranded Galapagos finally finds buyer for cell therapies
Lakefront Biotherapeutics—the new name for Belgium’s Galapagos Therapeutics—has found a buyer for its unwanted cell therapy pipeline.
James Waldron
Oct 15, 2026 4:09am
Rebranded biotech lands $125M for rescued Galapagos assets
Apr 28, 2026 7:00am
Gilead's $2.2B Ouro buy delivers TCE, new purpose for Galapagos
Mar 24, 2026 3:34am
Galapagos took €228M hit from cell therapy wind-down
Feb 24, 2026 6:30am
Galapagos' last immunology asset posts mixed results
Dec 19, 2025 6:05am
Fierce Biotech's Rotten Tomatoes of 2025
Dec 16, 2025 4:30am